Kenneth Warwick Nelson III - 12 Jun 2024 Form 4 Insider Report for HeartBeam, Inc. (BEAT)

Role: Director
Signature: /s/ Kenneth Warwick Nelson III
Issuer symbol: BEAT
Transactions as of: 12 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Jun 2024, 17:12:57 UTC
Previous filing: 17 Jul 2023
Next filing: 02 Oct 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAT	Common Stock	Award	$0	+33,185	+35%	$0.000000	127,147	12 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BEAT	Common Stock (right to buy)						70,000	12 Jun 2024	Common Stock	70,000	$2.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.
F2	The option was granted on April 10, 2024, and one thirty-sixth of the Shares shall vest each month after vesting commencement date. All shares subject to the option shall accelerate and vest in full upon the Company's termination of optionee's engagement following a change in control.

Content

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

The option was granted on April 10, 2024, and one thirty-sixth of the Shares shall vest each month after vesting commencement date. All shares subject to the option shall accelerate and vest in full upon the Company's termination of optionee's engagement following a change in control.